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Abstract 
Background: The oleaginous yeast, Yarrowia lipolytica, has been utilized as an industrial host for about 60 years for 
various applications. Recently, the metabolic engineering of this host has become increasingly popular due to its abil-
ity to accumulate lipids as well as improvements made toward developing new genetic tools. Y. lipolytica can robustly 
metabolize glucose, glycerol, and even different lipid classes. However, little is known about its xylose metabolizing 
capability. Given the desirability of having a robust xylose utilizing strain of Y. lipolytica, we performed a comprehen-
sive investigation and elucidation of the existing components of its xylose metabolic pathway.
Results: A quick and efficient means of determining functionality of the candidate xylose pathway genes (XYR, XDH, 
and XKS) from Y. lipolytica was desirable. We challenged Escherichia coli mutants lacking either the xylose isomerase 
(xylA) gene or the xylulose kinase (xylB) gene to grow on xylose minimal media by expressing the candidate genes 
from Y. lipolytica. We showed that the XKS of Y. lipolytica is able to rescue xylose growth of E. coli ΔxylB, and the XDH 
enabled growth on xylitol, but not on xylose, of E. coli ΔxylA. Overexpression of XKS and XDH in Y. lipolytica improved 
growth on xylitol, indicating that expression of the native enzymes was limiting. Overexpression of XKS and XDH in 
Y. lipolytica also enables robust growth on xylose under high nitrogen conditions without the need for adaptation. 
These results prove that a complete xylose pathway exists in Y. lipolytica, but the pathway is poorly expressed. To elu-
cidate the XYR gene, we applied the E. coli ΔxylA xylose growth challenge with 14 candidate XYR genes and XDH. The 
XYR2 candidate was able to rescue growth of E. coli ΔxylA xylose on minimal media.
Conclusions: While a native xylose pathway exists in Y. lipolytica, the microorganism’s inability to grow robustly on 
xylose is an effect of cryptic genetic circuits that control expression of key enzymes in the metabolic pathway. We 
have characterized the key enzymes associated with xylose metabolism and demonstrated that gene regulatory 
issues can be overcome using strong hybrid promoters to attain robust growth on xylose without adaptation.
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Background
Metabolic engineering has made significant advance-
ments in the last decade toward engineering microbes 
that produce a variety of industrially useful products 
[1]. A large emphasis has been placed on developing 
downstream metabolic pathways to produce novel prod-
ucts, including alkanes [2], alcohols [3–5], aldehydes 
[6–8], esters [4, 9], fatty acids [4, 10, 11], and lipid-based 
products [4, 12] from traditional carbon feedstocks such 
as glucose. Advancements in lignocellulose degradation 
have made unconventional sugars abundantly available 
[13, 14]. The hemicellulose in plant biomass is the third 
most abundant polysaccharide on earth and is made pri-
marily of xylose, with small amounts of galactose and 
arabinose. The increasing availability of these alternative 
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sugars has made upstream metabolic engineering for 
alternative sugar consumption critical to improve eco-
nomical microbial production of chemicals. As result, 
much effort has gone toward engineering traditional 
industrial hosts such as S. cerevisiae for efficient xylose 
consumption [15].
The non-conventional yeast, Yarrowia lipolytica, has 
been utilized as an industrial host for about 60 years for 
various applications, including single-cell protein and 
citric acid production [16]. As an oleaginous microor-
ganism, Y. lipolytica can naturally accumulate greater 
than 20 % of its dry cell weight as neutral lipids, typically 
achieving up to 40–50 % lipid. More recently, this yeast 
has been engineered to produce high lipid titers and up 
to 90 % of its dry cell weight as lipids [16, 17]. This innate 
capacity to produce fatty acids and lipids has sparked 
growing interest in metabolic engineering of Y. lipolytica 
to produce fatty acid-derived chemicals. These efforts 
have been enabled by the availability of genome sequence 
data [18], as well as a growing genetic engineering 
toolkit, including integration and episomal vectors, finely 
tuned promoters, and genome editing by CRISPR–Cas9 
[19–24]. The naturally high lipid production capabilities 
of Y. lipolytica have been harnessed for the production 
of lipids [25], omega-3 fatty acids [12], and dicarboxylic 
acids [26, 27].
Yarrowia lipolytica can robustly metabolize glucose, 
glycerol, alkanes, and even different lipid classes [27]. 
However, little is known about its xylose metabolizing 
capability. Most xylose metabolizing yeast, such as Schef-
fersomyces stipitis, utilizes the oxidoreductase pathway; 
however, Piromyces utilizes the isomerase pathway, likely 
through horizontal gene transfer from bacteria that also 
commonly use the isomerase pathway (Fig. 1a) [28, 29]. 
In the literature, there are conflicting reports concern-
ing xylose consumption by Y. lipolytica [25, 30–32]. Our 
results show that Y. lipolytica is unable to naturally grow 
on xylose as the sole carbon source. However, we do 
observe a small amount of growth on xylitol, an interme-
diate in the oxidoreductase xylose pathway. This suggests 
that Y. lipolytica contains at least a partially active xylose 
pathway.
Given the desirability of having a robust xylose utiliz-
ing strain of Y. lipolytica, we performed a comprehensive 
investigation and elucidation of the existing components 
of its xylose metabolic pathway. Initially, we used bioin-
formatics tools to identify candidate genes that could be 
responsible for xylose metabolism. Candidate genes were 
overexpressed in E. coli deficient in the xylose genes (xylA 
and xylB) to quickly and easily identify positive candi-
dates through in  vivo complementation. Active genes 
were assayed in vitro to confirm activity and then over-
expressed in Y. lipolytica to observe changes in growth 
using both xylitol and xylose. Overall, our study shows 
that Y. lipolytica possesses a functional and complete but 
cryptic metabolic pathway for xylose, and this knowledge 
was used to engineer robust utilization of xylose.
Results
Exploring native xylose and xylitol metabolism
There have been conflicting reports in the literature 
about the endogenous ability of Y. lipolytica to metabo-
lize xylose [25, 30–32]. Our results with Y. lipolytica PO1f 
strain show that the microorganism is unable to utilize 
xylose as a sole carbon source (Fig. 1b). However, Y. lipo-
lytica does exhibit weak growth in D-xylitol (Fig.  1b). 
Therefore, we first sought to identify whether there were 
any candidate genes coding for enzymes in the oxido-
reductase pathway of xylose metabolism in Y. lipolytica. 
In yeast systems, the oxido-reductase pathway is the 
major type of metabolic pathway for xylose utilization. 
Well-characterized xylose metabolism enzymes from S. 
stipitis (XYR: XP_001385181, XDH: XP_001386982, and 
XKS: XP_001387325) were used as the query to BLAST 
against the Y. lipolytica CLIB 122 protein database. 
The results of the top hits for each of the hypothetical 
enzymes, xylose reductase (XYR1), xylitol dehydroge-
nase (XDH), and xylulose kinase (XKS) are summarized 
(Fig. 1c).
Since no growth was observed with xylose as the sole 
carbon source, xylitol was initially used for growth. 
The native mRNA expression and extent of inducibility 
(∆∆CT) of these three candidate genes were measured 
using quantitative PCR (Fig. 2a, b). We observed that of 
the three genes, XDH is the only gene that is induced with 
xylitol (Fig.  2b). XYR1 is constitutively expressed, while 
XKS is weakly expressed (Fig.  2a). These results suggest 
that one of the major bottlenecks for xylose and xylitol 
metabolism could be the limited expression of XKS.
E. coli growth challenge to test candidate xylose 
metabolism genes in Y. lipolytica
Since growth on xylose by Y. lipolytica was not observed, 
attaining further information on the potential xylose 
metabolic pathway in this host would be difficult and 
unproductive. A quick, inexpensive, and efficient means 
of determining if the candidate genes (XYR1, XDH, and 
XKS) are active was desirable. Instead of using Y. lipol-
ytica, we devised a metabolic engineering strategy using 
Escherichia coli. We challenged E. coli mutants lack-
ing either the xylose isomerase (xylA) gene or the xylu-
lose kinase (xylB) gene to grow on xylose minimal M9 
media by complementation with the candidate genes 
from Y. lipolytica (Fig.  3a). If the Y. lipolytica candidate 
genes were active toward their expected substrates and 
expressed functionally in E. coli, then they would rescue 
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the growth phenotype of either E. coli ΔxylA or E. coli 
ΔxylB.
First, the E. coli BW25113 ΔxylB from the Keio collec-
tion [33] was acquired and transformed with a plasmid 
harboring XKS (Y. lipolytica) under the pLlacUV5 IPTG 
inducible promoter. An E. coli BW25113 ΔxylB harbor-
ing a negative plasmid was used as a negative control, and 



























































Fig. 1 Preliminary assessment of xylose and xylitol metabolism in Y. lipolytica. a Eukaryotic (blue) and prokaryotic (red) xylose pathways typical 
found in nature. The oleaginous yeast, Y. lipolytica, is most likely to have a xylose reductase (XYR), xylitol dehydrogenase (XDH), and xylulose kinase 
(XKS). b Growth curve of Y. lipolytica PO1f (WT) in xylitol (black) and xylose (white) YSC media. c The top hits from BLAST analysis of the Y. lipolytica 




















































Fig. 2 mRNA Quantification of Y. lipolytica grown on xylitol. a Comparison of mRNA levels of the candidate xylose pathway when grown on xylitol 
vs glucose. mRNA levels are represented as copy number relative to the copy number of β-actin. b Normalized expression using the ∆∆CT method 
of the candidate xylose metabolism genes when grown on xylitol vs glucose. All error bars represent SD. (n = 3)
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These strains were inoculated from overnight cultures 
into M9 media containing 10 g L−1 xylose and allowed to 
grow (Fig. 3b). The E. coli ΔxylB mutant expressing XKS 
was found to grow on xylose, while the negative control 
was unable to grow on xylose. This indicates that the XKS 
candidate from Y. lipolytica is in fact a functional xylu-
lose kinase. In addition, this shows that the E. coli xylose 
challenge allowed for quick and simple confirmation of 
the candidate enzyme function.
Next, the XYR1 and XDH genes were tested in the E. 
coli xylose challenge using the E. coli BW25113 ΔxylA 
acquired from the Keio collection [33]. The E. coli ΔxylA 
strain was transformed with a plasmid harboring XYR1 
and XDH on an operon under the pLlacUV5 IPTG 
inducible promoter as before, and the strains were chal-
lenged to grow on xylose. Again, a negative control strain 
and the WT strain were used as a negative and positive 
control. In this case, we did not observe any growth of 
the strain harboring the XYR1 and XDH strain in xylose 
media (data not shown). However, when challenging 
these strains to grow on xylitol rather than xylose 
(Fig.  3c), we observed that the strain harboring XYR1 
and XDH grows on xylitol, while both the negative and 
WT controls were unable to grow on xylitol. This proves 
that the XDH candidate is in fact a functional xylitol 
dehydrogenase.
The E. coli xylose growth challenge proved valuable 
in quickly confirming the functionality of the XDH and 
XKS candidates of xylose metabolism enzymes from Y. 
lipolytica. While the XYR1 enzyme did not enable E. coli 
ΔxylA to grow in xylose, we cannot rule out the possibil-
ity that this enzyme simply does not express function-
ally in E. coli. Nonetheless, the ease and rapidity of these 
experiments proved valuable.
Overexpression and knockout studies of XDH and XKS in Y. 
lipolytica
Having successfully confirmed the activity of the Y. lipo-
lytica XDH and XKS gene in the E. coli xylose growth 



































E. coli xylA: XYR+XDH


























E. coli xylB: XKS
E. coli xylB: (-)
E. coli WT
Fig. 3 Elucidation of function of XDH and XKS using E. coli and further studies in Y. lipolytica. a Schematic of the xylose growth challenge in E. coli 
using mutants lacking a native gene (xylA or xylB) in the xylose pathway and challenging E. coli to use the candidate Y. lipolytica enzyme(s) instead. 
b Growth curves of E. coli ΔxylB strains in the xylose challenge: E. coli ΔxylB expressing XKS (Plasmid 2) from Y. lipolytica (blue), wild-type (BW25113) 
positive control (white), and E. coli ΔxylB negative control (Plasmid 1) (black). c Growth curves of E. coli ΔxylA strains in the 1 % xylitol minimal media: 
E. coli ΔxylA expressing XYR1-XDH (Plasmid 3) from Y. lipolytica (blue), Wild type (BW25113) control (white), and E. coli ΔxylB negative control (Plasmid 
1) (black). All error bars represent SD. (n = 3)
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studies in Y. lipolytica to observe the effect of the XDH 
and XKS genes on xylitol growth. The XDH and XKS 
genes were expressed under the UAS1B8-TEFMIN syn-
thetic hybrid promoter previously characterized in 
the literature [20, 21, 24]. We measured the growth of 
Y. lipolytica in YSC media containing 2  % (w/v) xylitol, 
wherein we expressed both genes together and each gene 
individually (Fig.  4a). Individually expressing either the 
XDH or the XKS gene enabled small improvements in 
the rate of growth. The maximum cell density of the XKS 
expressing strain was higher (OD600  ~3) than the XDH 
(OD600  ~2.15) expressing strain, perhaps indicating that 
XKS is somewhat more limiting that the XDH. Coexpres-
sion of XDH and XKS showed substantial improvement 
over the individually expressed strains. The strain grew 
consistently in a linear fashion to reach a final OD600 >11, 
which is nearly 10-fold higher that the wild-type Y. lipo-
lytica (OD600  ~1.25). The substantial improvement in 
growth by the XDH/XKS double expression strain sug-
gests that expression of both enzymes are rate limiting. 
This is in agreement with the qPCR results of the native 
strain grown on xylitol (Fig. 2a, b), where we observe that 
the XKS gene has nearly undetectable mRNA levels in 
xylitol and that the XDH gene is induced by xylitol ~15-
fold; however, the expression is still low relative to β-actin 
expression (~0.2).
Given the improved growth of Y. lipolytica on xylitol, 
we tested the essentiality of these genes for growth on 
xylitol by conducting gene disruption studies. Here, we 
applied an early example of the CRISPR–Cas9 system to 
Y. lipolytica [19] to generate a frame shift mutation in the 
target gene, rendering the protein non-functional. We 
applied CRISPR–Cas9, as described recently, to disrupt 
either the XKS or XDH gene in the Y. lipolytica genome. 
These mutants were tested for their ability to grow on 
xylitol containing YSC media (Fig.  4b). As expected, 
both the XKS and XDH disrupted mutants were unable 
to grow on xylitol containing YSC media, demonstrating 
the essentiality of XDH and XKS genes for the xylose/
xylitol metabolism of Y. lipolytica.
Overexpression of XDH and XKS enables Y. lipolytica 
growth on Xylose
The observed functionality of native XDH and XKS gave 
us the basis to begin engineering efforts to enable Y. lipo-
lytica to grow on xylose. All we initially required was the 
addition of a functional XYR to express along with the Y. 
lipolytica XDH and XKS genes. The introduction a XYR 
gene into other hosts, such as S. cerevisiae, is common 
and has been demonstrated with several known xylose 
reductases, most commonly, the XYR of S. stipitis [15]. 
However, while running initial control experiments with 
the double overexpression of XDH and XKS in Y. lipol-
ytica, we found that this strain can indeed grow on xylose 
as the sole carbon source (Fig. 5a). In fact, the strain was 
able to reach high cell densities (OD600 ~25), comparable 
with the cell densities achieved with glucose as the sole 
carbon source. Interestingly, this strain did not require 
any adaptation period, which is often necessary when 
engineering yeast to utilize xylose [15]. This strain was 
able to accomplish twice the cell density in comparison to 
growth on xylitol as the sole carbon source and a fast time 
to stationary phase (162 vs 236 h). This surprising result 
indicated that Y. lipolytica in fact contains a functional 
xylose reductase, and that expression of a heterologous 















































Fig. 4 Expression of XDH and XKS improves growth of Y. lipolytica on Xylitol. a Grow curves of Y. lipolytica PO1f strains in 2 % xylitol YSC media while 
expressing the following genes: XKS (Plasmid 21) (white circle), XDH (Plasmid 22) (white diamond), both XKS and XDH (Plasmids 21 and 22) (teal), and 
empty vector control (plasmid 18) (black). b Cell density (OD600) of Y. lipolytica PO1f mutants (−XKS or −XDH) in 2 % xylitol YSC media after 96 h: 
PO1f wild-type control harboring Plasmid 18, −XKS mutant harboring Plasmid 27. −XDH mutant harboring Plasmid 24. All error bars represent SD. 
(n = 3)
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achieve robust xylose utilization. Overexpression of XDH 
and XKS resulted in nearly identical growth compared 
to the empty vector transformed wild-type Po1f (Addi-
tional file 1), indicating that XDH and XKS only confer a 
growth advantage in xylose and not in glucose.
Co-utilization studies of the engineered strain with 
glucose and xylose showed that while Y. lipolytica first 
consumes glucose as the preferred carbon source, rapid 
utilization of xylose is observed when glucose in the 
media falls below a critical concentration of  ~2  g L−1 
(Fig. 5b). It is unclear if this lag is due to regulation pre-
venting xylose metabolism, or if it simply results from 
the lag in gene expression of the overexpressed XDH 
and XKS genes. There is little xylose consumption dur-
ing the first 48 h of growth with xylose as the sole carbon, 
so even if both substrates were being co-utilized, xylose 
consumption would be insignificant compared to glucose 
consumption. Furthermore, the growth rate when xylose 
is being metabolized in the co-utilization experiment is 
similar to the rate of growth using glucose alone. This 
suggests that glucose metabolism is preferred, although 
the strain is then primed for rapid xylose metabolism 
post-glucose utilization.
Searching for the missing XYR and enzymatic 
characterization
To find the missing XYR gene, we revisited our original 
BLAST analysis of xylose reductase and reapplied the E. 
coli xylose growth challenge. Since the growth challenge 
successfully confirmed the activity of XDH and XKS, 
there was justification to validate the XYR gene using the 
same methods. We screened 13 XYR candidates as well 
as a short chain dehydrogenase/reductase (SDR) from 
Y. lipolytica, known to act on fructose [34] (Additional 
file  2). Each of the 14 genes was expressed along with 
XDH (YALI0E12463g) as a single operon. Each plasmid 
was introduced into E. coli ΔxylA, and the strains were 
challenged to grow on xylose M9 media. As a positive 
control, the XYR gene from S. stipitis was tested in the 
xylose challenge. In addition, the strains were allowed to 
grow for a considerably longer time. After the 6th day, 
rapid growth was observed from the XYR2 gene (YAL-
I0F18590g), and some growth was observed from the 
XYR of S. stipitis (Fig. 6a). The prolonged time to observe 
growth could be due to redox imbalances innate to E. 
coli, but nevertheless demonstrates XYR2 is a functional 
xylose reductase.
With a complete xylose pathway now elucidated, we 
expressed the XYR1, XYR2, and XDH in E. coli BL21 
cells for enzymatic characterization. Crude cell lysates 
were prepared, and activities were measured with their 
respective substrate and NAD(P)H cofactors. Activ-
ity from XYR2 and XDH was detected, but no activity 
from XYR1 was detected (Fig. 6b). The XDH enzyme was 
found to be highly active (~18.5 μg min−1 mg−1) although 
mostly insoluble in E. coli (Additional file 3). The XYR1 
enzyme was found to be insoluble in E. coli, and no 
activity was measured in E. coli lysates. Since XYR1 was 
insoluble, this result does not necessarily reflect a lack 
of activity in Y. lipolytica. The XYR2 enzyme, however, 
was found to be soluble, and its activity was estimated to 
be ~5–6 μg min−1 mg−1, about threefold lower than the 
XDH enzyme. E. coli lysate activity was normalized to 
specific protein determined by SDS–PAGE densitometry.
We overexpressed XYR1 and XYR2 in Y. lipolytica to 
ascertain the activity of the reductases in their native 
environment. Strains were grown in 2 % oleic acid YSC 












































































PO1f: XDH + XKS
Xylose Concentration
Fig. 5 Expression of XDH and XKS enables growth of Y. lipolytica on Xylose. a Growth curve and xylose consumption of Y. lipolytica PO1f express-
ing XKS and XDH (Plasmids 21 and 22, respectively) in 2 % Xylose YSC media. b Growth curve and xylose/glucose consumption of Y. lipolytica PO1f 
expressing XKS and XDH (Plasmids 21 and 22, respectively) in 2 % xylose YSC media. All error bars represent SD. (n = 3)
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maximum expression of the synthetic hybrid promoter. 
Cell lysates were prepared and assayed for XYR activ-
ity (Fig. 6c). A control strain harboring an empty vector 
was also assayed. Both XYR1 and XYR2 showed statisti-
cally similar amounts of activity (0.08–0.1 U), indicating 
that both XYR1 and XYR2 are functional reductases. The 
control strain showed small amounts of activity likely due 
to the constitutive expression of the XYRs as determined 
by qPCR (Fig. 2a). Y. lipolytica lysate activity was normal-
ized to total protein determined by a Bradford assay.
qPCR analysis of the xylose utilizing Y. lipolytica strain
We compared mRNA levels of four xylose metabo-
lism genes (XYR1, XYR2, XDH, and XKS) from the 
engineered XDH + XKS strain and the wild-type PO1f. 
mRNA expression relative to a reference gene (β-actin) 
was measured by qPCR at early exponential phase and at 
late exponential/early stationary phase, respectively. We 
found that in either phase of growth, expression levels of 
XYR1 and XYR2 genes are always similar to expression 
levels of β-actin, indicating constitutive expression. This 
observation is consistent across the XDH +  XKS strain 
and the wild type. Expression of the XDH and XKS genes 
under the control of the UAS1B8-TEFMIN promoter 
have similar transcriptional levels compared to β-actin 
(0.9 and 1.4, respectively) in early exponential phase, 
but expression increases  ~10-fold in stationary phase 




















































































































Fig. 6 Elucidating XYR genes in Y. lipolytica and enzyme characterization. a Screening for the missing XYR gene from Y. lipolytica by revisiting the E. 
coli xylose challenge. Cell densities of E. coli ΔxylA strains grown in 1 % xylose minimal media for 6 days expressing a candidate XYR (1–13, or SDR) 
and XDH (Plasmids 3–16) from Y. lipolytica (teal) were measured. The known S. stipitis XYR (black) and XDH (Y. lipolytica) (Plasmid 17) were used as 
a positive control. b Enzyme assay of XDH in BL21 cell lysates using NAD+ cofactor and xylitol as a substrate. One unit is defined as the reduction 
of 1 μmol NAD+ per min per mg protein. Enzyme assay of XYR1 and XYR2 in BL21 cell lysates using NADPH cofactor and xylose as a substrate. 
One unit is defined as the oxidation of 1 μmol NADPH per min per mg protein. Protein concentrations were calculated by densitometry from the 
coomassie image after SDS–PAGE electrophoresis. c Enzyme assay of XYR1 and XYR2 in Y. lipolytica cell lysates using NADPH cofactor and xylose as 
a substrate. XYR1 and XYR2 overexpressed using Plasmids 32 and 33. Control strain harboring plasmid 18 was also tested. One unit is defined as the 
oxidation of 1 μmol NADPH per min per mg protein. Protein concentrations are calculated by Bradford Assay for total cellular protein. All error bars 
represent SD. (n = 3)
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expression during late exponential phase is characteristic 
of this hybrid promoter system [21, 24].
Lipid analysis of the engineered xylose utilizing Y. lipolytica
A comparison of lipid production and the lipid profile 
was made between the engineered xylose strain grown on 
xylose and wild-type (PO1f) grown on glucose. High and 
low nitrogen conditions were tested (Fig.  8a–c). Under 
high nitrogen conditions, the xylose strain reached a 
dry cell weight nearly as large as the wild type grown on 
glucose (3 vs 4 g L−1), while accumulating a higher per-
centage of lipids (10 vs 6  % of DCW). In low nitrogen 
conditions, the xylose strain performed less well in terms 
of dry cell weight as compared with wild type (1 vs 3  g 
L−1), and accumulated slightly less lipids as percentage of 
dry cell weight (21 vs 29 %).
Compared with high nitrogen conditions, overall lower 
final cell mass accumulation and growth rates were 
observed under low nitrogen for the engineered strain 
(grown on xylose) compared to the wild type (grown on 
glucose). This is a result of a global regulatory process 
known to occur in Y. lipolytica where there is a shift from 
cell growth to lipid accumulation during cell maturation 
under nitrogen limitation. However, a bigger difference 
in dry cell weight is observed between the two nitrogen 
conditions with engineered strain (~66  %) compared 
with the wild-type strain (~25 %). This could be a com-
binatorial effect of using hybrid promoters that elicit 
strongest expression strength towards late exponential 
and stationary phase and the lack of adaptation of the 
engineered strain, which may contribute to improved 
growth and lipid yields. Undoubtedly, there exist some 
bottlenecks associated with the initial xylose utilizing 
strain when compared to glucose utilization that need to 
be addressed in the future studies.
Discussion
In this study, we have expanded the substrates utilized 
by Y. lipolytica to include xylose. We described a cryp-
tic xylose metabolism pathway in Y. lipolytica, and 
elucidated the full set of enzymes responsible for the con-
flicting reports in the literature with regard to its xylose 
utilization capabilities. To provide a more complete 
understanding of the innate capabilities of Y. lipolytica 
for xylose metabolism, we have studied the biochemi-
cal and metabolic roles of predicted xylose metabolism 
enzymes and concluded that XYR1, XYR2, XDH, and 
XKS are functional, and that XDH and XKS are required 
for xylose metabolism. Using E. coli complementation 
assays and measurements in Y. lipolytica with xylitol 
as a substrate, we identified the XDH and XKS steps as 
key bottlenecks in xylose metabolism. We also identi-
fied the essentiality of these enzymes in xylitol metabo-
lism. Furthermore, we found that overexpression of XDH 
and XKS resulted in robust growth on xylose, reaching 
an OD600 of 25 after 7 days. This is approximately three 
times the cell titer shown by Ryu et al. in a recent study 
on xylose metabolism that was published, while we pre-
pared this manuscript [35]. Finally, we showed that the 
lipids produced by Y. lipolytica with overexpression of 
XDH and XK were nearly identical in composition to 

























PO1f: XDH + XKS (Xylose) - Exponential Phase
PO1f: XDH + XKS (Xylose) - Stationary Phase
PO1f: (Glucose) - Exponential Phase
PO1f: (Glucose) - Stationary Phase
Fig. 7 mRNA quantification of the xylose utilizing Y. lipolytica strain. a Early and late exponential phase measurement of mRNA copy number 
relative to β-actin mRNA copy number for the xylose pathway in Y. lipolytica PO1f expressing XKS and XDH (Plasmids 21 and 22, respectively) (blue) 
grown in 2 % xylose YSC–LEU–URA media compared to Y. lipolytica PO1f harboring Plasmids 18 (empty vectors) (black) grown in 2 % glucose YSC-
LEU–URA. All error bars represent SD. (n = 3)
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By applying a xylose growth challenge strategy using E. 
coli mutants lacking a native xylose gene (xylA or xylB) 
and forcing E. coli to utilize the candidate Y. lipolytica 
enzymes, we were able to quickly confirm the XDH and 
XKS enzyme in the xylose pathway. The expression of 
XDH and XKS (Y. lipolytica) allowed the E. coli mutants 
to grow on xylitol and xylose, respectively. To find the 
missing XYR gene, 14 candidate XYR genes were tested 
in the E. coli ΔxylA growth challenge. The XYR2 gene 
was the only candidate gene that enabled E. coli ΔxylA 
to grow on xylose. XYR2 enabled faster growth to higher 
titers than XYR from S. stipitis in the E. coli growth chal-
lenge. Enzymatic characterization of XYR2 and XDH in 
E. coli lysates showed robust activity from both enzymes. 
No activity was detected from XYR1, but this enzyme 
was found to be insoluble in E. coli, so we could not 
draw a definitive conclusion about the relative activities 
of these two enzymes. However, overexpression of the 
XYR1 or XYR2 gene in Y. lipolytica results in similar lev-
els of xylose reductase activity.
We found that XYR1 and XYR2 are constitutively 
expressed in Y. lipolytica and do not undergo carbon cat-
abolite repression in glucose; however, mRNA expression 
is still low compared to β-actin. Activity assays of XYR1 
and XYR2 overexpressed in Y. lipolytica show statistically 
equal activity. We have definitively shown that XYR2 has 
activity approximately equal to that measured for XYR1 
by Ryu et  al. and that mRNA expression of these two 
genes is approximately equal [35]. We suggest that XYR1 
and XYR2 may serve redundant roles.
qPCR analysis of the wild type grown on xylitol as com-
pared to glucose showed inducibility of the XDH gene 
and no inducibility of the XKS gene. In strains where 
we overexpress XDH and XKS, we observe significant 
mRNA copy number driven by the strong hybrid pro-
moters used. We do not observe any xylose inducible 
expression from either XYR1 or XYR2. Ryu et al. meas-
ured relative mRNA using their xylose adapted wild-type 
Y. lipolytica and saw mild inducibility of all three genes 
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c
Fig. 8 Dry Cell weight and lipid analysis of the xylose utilizing strain as compared to glucose. a Dry cell weight (DCW) measurement of Y. lipolytica 
PO1f harboring Plasmids 21 and 22 (XKS and XDH) grown in high and low nitrogen media containing 2 % xylose and Y. lipolytica PO1f harboring 
Plasmid 18 (empty vector) grown in high and low nitrogen media containing 2 % glucose: xylose and high nitrogen (blue), xylose and low nitrogen 
(striped blue), Glucose and high nitrogen (black), glucose and low nitrogen (striped black). b Lipid content as a percentage of DCW for the strains 
and culture conditions listed above. c Fatty acid profile as a percentage of total lipids for the strains and culture conditions listed above: xylose and 
high nitrogen (blue), xylose and low nitrogen (striped blue), glucose and high nitrogen (black), glucose and low nitrogen (striped black). All error bars 
represent SD. (n = 3)
Page 10 of 15Rodriguez et al. Biotechnol Biofuels  (2016) 9:149 
specific calibration curves instead of simply using the 
∆∆Ct method to determine the extent to which genes 
were being expressed. Overall, the expression level is 
low relative to the house keeping gene, β-actin. Strictly 
going by expression level, XKS is expressed the weakest 
implying it is a possible bottleneck in xylose metabolism. 
By overexpressing XDH and XKS genes in Y. lipolytica, 
we showed that the double overexpression strain grew 
to  ~10-fold higher cell density (OD600  >10) on xylitol 
compared to the wild type. Expressing XKS alone yielded 
better growth than expressing XDH alone, which is in 
agreement with the qPCR results. These results indicated 
that native expression of both XDH and XKS is insuffi-
cient to achieve robust grow on xylitol.
Overexpressing XDH and XKS genes in Y. lipolytica 
also enabled robust growth on xylose as the sole carbon 
source without the need for adaptation. This surpris-
ing result proved that Y. lipolytica contains a complete 
xylose pathway including functional XYRs, which was 
not originally identified when we only examined XYR1. 
Disruption of the XDH and XKS genes using a recently 
developed CRISPR–Cas9 system [19] showed that both 
genes are essential for growth on xylitol.
Our approach of activating the cryptic xylose metabo-
lism by overexpression of rate limiting enzymes yielded 
a xylose metabolizing strain that remarkably did not 
require any adaptation. Ryu et al. showed that the wild-
type strain requires adaptation to get relatively subtle 
growth on xylose [35]. Likewise, Tai showed that when 
the oxido-reductase pathway was engineered into Y. lipo-
lytica adaptation was also required [32]. The explanation 
for what occurs during this adaptation remains an active 
area of inquiry.
Interestingly, in co-utilization experiments, we observe 
a much more rapid depletion of xylose, suggesting that 
the Y. lipolytica is capable of rapid xylose metabolism if 
additional bottlenecks are addressed. Rate of growth on 
xylose as a sole carbon source was still was slower than 
growth on glucose (168 vs  ~48  h), indicating that fur-
ther bottlenecks exist. Potential bottlenecks for xylose 
metabolism are well appreciated and include limitations 
in transporter activity/expression, redox balance, enzyme 
activity, downstream pentose phosphate enzymes, and 
due to the nature of the hybrid promoters used in this 
study where expression is several folds lower in early 
exponential phase as compared to late exponential phase.
Conclusions
We have elucidated the native pathway for xylose metab-
olism in Y. lipolytica. The microorganism’s inability to 
grow robustly on xylose is the result of insufficient activa-
tion of native xylose metabolism genes. In this publica-
tion, we have characterized the key enzymes associated 
with xylose metabolism and demonstrated that gene 
regulatory issues can be overcome using strong hybrid 
promoters to attain robust growth on xylose without 
adaptation. Constitutive overexpression of the cryptic 
XKS gene and weakly inducible XDH gene can result in 
growth to high cell densities. We also note comparable 
lipid accumulation profiles under high nitrogen condi-
tions for strains metabolizing glucose and xylose as a sole 
carbon source, respectively. Under low nitrogen condi-
tions, however, the lipid yields are somewhat diminished 
in the xylose metabolizing strain using xylose as the sole 
carbon source. Improvements to growth rates and lipid 
accumulation can be attained by the development of bet-
ter genetic tools that confer strong, constitutive gene 
expression to key genes early on during growth. Further-
more, improving the flux of xylose into the cell via the 
use of xylose-specific transporters could aid in more effi-
cient uptake for metabolism.
Methods
Reagents
All chemicals were purchased from Sigma unless other-
wise stated. All restriction enzymes, DNA ligases, and 
DNA polymerases used for cloning and PCR were pur-
chased from New England Biolabs (NEB) unless other-
wise stated. Plasmid minipreps, PCR purifications, and 
gel extractions were done using the Zymo Zyppy Plasmid 
Miniprep Kit, and Zymo DNA Clean and Concentrator 
5. Genomic DNA from Y. lipolytica was extracted using 
the E.Z.N.A. Yeast DNA kit (Omega Biotek). All oligonu-
cleotides and gBlocks® were purchased from IDTDNA. 
Xylose assays were performed using the D-Xylose Assay 
Kit (Megazyme). Glucose assays were done using glucose 
oxidase and horseradish peroxidase enzymes purchased 
from Sigma.
E. coli strains and culture conditions
The strains used in this study are summarized in Table 1. 
Escherichia coli DH10β cells from New England Biolabs 
(NEB) (Ipsich, MA) were used for cloning and propaga-
tion of plasmids in Luria–Bertani (LB) media supple-
mented with 200  μg  mL−1 ampicillin. E. coli BW25113 
ΔxylA and ΔxylB were obtained from Coli Genetic Stock 
Center (CGSC) at Yale University (New Haven, CT). E. 
coli BL21 (DE3) was used as the host organism to study 
functional xylose genes of Y. lipolytica.
Transformation of Y. lipolytica and culture conditions
Yarrowia lipolytica strain PO1f (MATa leu2-270 ura3-
302 xpr2-322 axp1) (ATCC no. MYA-2613) was used 
for gene deletion, overexpression and growth studies. 
Transformations of Y. lipolytica were performed using 
the lithium acetate method [23]. General Y. lipolytica 
Page 11 of 15Rodriguez et al. Biotechnol Biofuels  (2016) 9:149 
growth was performed in rich YPD. Growth of transfor-
mants was done in yeast synthetic complete (YSC) media 
that contained 6.7 g L−1 yeast nitrogen base (YNB) from 
MP Biomedicals (Santa Ana, CA) and complete synthetic 
media with the desired drop out (0.69 g L−1 CSM-LEU, 
0.77 g L−1 CSM-URA or 0.67 g L−1 CSM-LEU-URA) pur-
chased from Sunrise Science Products (San Diego, CA). 
Carbon sources used for the following experiments were 
either 2 % (w/v) d-glucose from Sigma Aldrich (St. Louis, 
MO), d-xylitol and d-xylose from Alfa Aesar (Haverhill, 
MA). Agar plates were made by adding 15 g L−1 agar. Y. 
lipolytica growth experiments were first pre-cultured 
in 2-mL culture tubes prior to inoculating 15-mL cul-
tures in 50 -mL baffled flasks and cultivated at 28 °C and 
215 rpm. Low nitrogen conditions were identical to high 
nitrogen media except ammonium sulfate was omitted 
from the media.
Identification of xylose metabolism genes
Putative xylose metabolism genes from Y. lipolytica 
were identified using S. stipitis genes for xylose reduc-
tase (NCBI: XP_001385181), xylitol dehydrogenase 
(NCBI: XP_001386982), and xylulose kinase (NCBI: 
XP_001387325) as the query. The BLAST search [36] was 
targeted to the Y. lipolytica CLIB 122 genome and indi-
vidual gene DNA sequences were compared to the PO1f 
genome sequence.
Plasmid construction
Yarrowia lipolytica expression cassettes were created 
from the base vector pSL16-UAS1B8-TEF(MIN)-hrGFP-
cyc1t harboring either the LEU2 or URA3 selective 
marker that has been previously synthesized and charac-
terized under different carbon conditions [21, 24]. Basic 
cassettes for gene knockout using CRISPR–Cas9 were 
obtained from Schwartz et al. [19]. All plasmids (Table 1) 
were cloned using sequence and ligation-independent 
cloning (SLIC) [9, 37], except for Plasmids 28 and 29, 
which were constructed using Gibson Assembly [38]. 
Oligonucleotides and gBlocks® used are listed in Addi-
tional file 4. The target gene(s) and vector fragments were 
amplified with primer pairs from the templates listed in 
Additional file  5. In some cases, vector fragments were 
prepared by digestion with restriction enzymes. The 
resulting fragments were purified and combined using 
SLIC. In summary, a 10 μL reaction containing 1 × NEB 
Buffer 2, 100–1000  ng of vector and insert fragments, 
and 0.25 μL (0.75 U) of T4 DNA Polymerase (NEB) was 
incubated at room temperature for 5–10 min, annd then 
placed on ice to stop the reaction. 2.5 μL of the solution 
was used for transformation of E. coli. Plasmids were ver-
ified by digestion with restriction enzymes and by DNA 
sequencing.
Xylose and xylitol growth challenge in E. coli
Escherichia coli BW25113 ΔxylB was transformed with 
Plasmids 1 and 2. E. coli BW25113 ΔxylA was trans-
formed with Plasmids 1 and 3–17. E. coli BW25113 was 
transformed with Plasmid 1. Colonies were inoculated 
into culture tubes containing 1  mL  M9 minimal media 
containing 10 g L−1 xylose with the appropriate antibiot-
ics and 1 mM IPTG. The strains were allowed to grow at 
28 °C, 215 RPM, for up 144 h. To test the XDH activity, 
xylitol was used instead of xylose.
Protein expression and lysate preparation
BL21(DE3) was transformed with Plasmids 29–31. Three 
colonies of each strain were inoculated into each culture 
tubes containing 3-mL LB with the appropriate antibi-
otics. Triplicate cultures were made for each strain. The 
overnight cultures were inoculated by 100-fold dilu-
tion into culture tubes containing 3-mL LB media with 
the appropriate antibiotics. The cultures were allowed 
to grow at 37  °C, 250  rpm, until an OD600 of  ~0.4 then 
induced with 1-mM IPTG. Cultures were allowed to 
express protein for 3–4  h at 28  °C, 215  rpm. Cultures 
were then centrifuged at 3000×g for 10 min. The media 
was discarded, and cell pellets were concentrated 10× 
(300 μL) in 100 mM PBS buffer and 1× BugBuster rea-
gent, and transferred to 1.5-mL tubes. Lysis was allowed 
to occur for 20  min at 28  °C with shaking (215 RPM). 
Lysates were then centrifuged at 15,000 rpm and 4 °C, for 
10 min. Soluble fractions were transferred to new chilled 
1.5-mL tubes. Insoluble fractions were suspended in 
100 mM PBS buffer.
For Y. lipolytica lysates, strains harboring either plas-
mid 18 (empty), 32 (XYR1), and 33 (XYR2) were grown 
were grown in 50-mL baffled flasks containing 15  mL 
of 2  % oleic acid YSC media with the appropriate drop 
out mix. Cultures were harvested in stationary phase for 
optimal protein expression. 15-mL cultures were washed 
twice in 100 mM PBS containing 5 % Tween80 prior to 
being harvested for lysis using the YeastBuster™ Protein 
Extraction Reagent from EMD Millipore (Billerica, MA). 
Protease inhibitors from Research Products International 
(RPI) (Mt. Prospect, IL) were added into the cell lysates 
to prevent protein degradation.
Enzyme assays of XDH, XYR1, and XYR2
Enzyme assay were performed at 28  °C in 96 well plate 
format using an Epoch 2 Microplate Spectrophotom-
eter (BioTek). Assay conditions were as follows: 40  μL 
100 mM PBS buffer mixed with 10 μL lysates, 100 μL of 
master mix (86  μL ddH2O, 10  μL 1  M PBS buffer, and 
4 μL of either 10 mM NADPH or NAD+), and 50 μL of 
either 1  % xylose, 100  mM xylitol, or ddH2O (blank). 
For XYR1 and XYR2 assays, the oxidation of NADPH 
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was followed for 5 min at 340 nm. For XDH assays, the 
reduction of NAD+ was followed for 5  min at 340  nm. 
One unit of activity is defined as the oxidation of 1 μmol 
of NADPH or reduction of 1 μmol of NAD+ per minute 
per milligram of protein. For E. coli lysate experiments, 
specific protein concentrations were determined by 
Table 1 Strains and plasmids
Genotype References
E. coli strains
 BW25113 rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLC78 [33, 39]
 BW25113
ΔxylA
BW25113 with xylA::kanR [33, 39]
 BW25113
ΔxylB
BW25113 with xylB::kanR [33, 39]
 BL21(DE3) fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS
λ DE3 = λ sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5
[40]
Y. lipolytica strains
 P01f MatA, leu2-270, ura3-302, xpr2-322, axp1-2 (ATCC no. MYA-2613) ATCC
 P01f–XKS P01f with alternate frameshift mutation in XKS gene This work
 P01f–XDH P01f with frameshift mutation in XDH gene This work
Plasmids
 1 AmpR, ColE1 ori; PlacUV5: fadD-AtfA, lacI
q [4]
 2 AmpR, ColE1 ori; PlacUV5: XKS (YALI0F10923 g), lacI
q This work
 3 AmpR, ColE1 ori; PlacUV5: XYR1 (YALI0D07634 g)-XDH (YALI0E12463 g), lacI
q This work
 4 AmpR, ColE1 ori; PlacUV5: XYR2 (YALI0F18590 g)-XDH (YALI0E12463 g), lacI
q This work
 5 AmpR, ColE1 ori; PlacUV5: XYR3 (YALI0A15906 g)-XDH (YALI0E12463 g), lacI
q This work
 6 AmpR, ColE1 ori; PlacUV5: XYR4 (YALI0B21780 g)-XDH (YALI0E12463 g), lacI
q This work
 7 AmpR, ColE1 ori; PlacUV5: XYR5 (YALI0C13508 g)-XDH (YALI0E12463 g), lacI
q This work
 8 AmpR, ColE1 ori; PlacUV5: XYR6 (YALI0B07117 g)-XDH (YALI0E12463 g), lacI
q This work
 9 AmpR, ColE1 ori; PlacUV5: XYR7 (YALI0E18348 g)-XDH (YALI0E12463 g), lacI
q This work
 10 AmpR, ColE1 ori; PlacUV5: XYR8 (YALI0042092 g)-XDH (YALI0E12463 g), lacI
q This work
 11 AmpR, ColE1 ori; PlacUV5: XYR9 (YALI0C09119 g)-XDH (YALI0E12463 g), lacI
q This work
 12 AmpR, ColE1 ori; PlacUV5: XYR10 (YALI0F06974 g)-XDH (YALI0E12463 g), lacI
q This work
 13 AmpR, ColE1 ori; PlacUV5: XYR11 (YALI0B15268 g)-XDH (YALI0E12463 g), lacI
q This work
 14 AmpR, ColE1 ori; PlacUV5: XYR12 (YALI0C00319 g)-XDH (YALI0E12463 g), lacI
q This work
 15 AmpR, ColE1 ori; PlacUV5: XYR13 (YALI0A19910 g)-XDH (YALI0E12463 g), lacI
q This work
 16 AmpR, ColE1 ori; PlacUV5: SDR (YALI0D18964 g)-XDH (YALI0E12463 g), lacI
q This work
 17 AmpR, ColE1 ori; PlacUV5: XYR (XP_001385181)-XDH (YALI0E12463 g), lacI
q This work
 18 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-(empty)-CYC1 [21]
 19 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-hrGFP-CYC1 [21]
 20 AmpR, ColE1 ori, URA3, CEN; UAS1B8-TEF-hrGFP-CYC1 [21]
 21 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-XKS (YALI0F10923 g)-CYC1 This work
 22 AmpR, ColE1 ori, URA3, CEN; UAS1B8-TEF-XDH (YALI0E12463 g)-CYC1 This work
 23 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-cas9-CYC1, TEF-HH-sgRNA-HDV [19]
 24 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-cas9-CYC1, TEF-HH-(XDH)sgRNA-HDV This work
 25 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-cas9-CYC1, SCRp’-tRNAp-
(PEX10)sgRNA
[19]
 27 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-cas9-CYC1, SCRp’-tRNAp-(XKS)sgRNA This work
 28 AmpR, ColE1ori; PT7lac: empty, lacI
q (pETDuet) Novagen
 29 AmpR, ColE1ori; PT7lac: 6xhis-XDH (YALI0E12463 g), lacI
q This work
 30 AmpR, ColE1ori; PT7lac: 6xhis-XYR1 (YALI0D07634 g), lacI
q This work
 31 AmpR, ColE1ori; PT7lac: 6xhis-XYR2 (YALI0F18590 g), lacI
q This work
 32 AmpR, ColE1 ori, LEU2, CEN; UAS1B8-TEF-XYR1-CYC1 This work
 33 AmpR, ColE1 ori, URA3, CEN; UAS1B8-TEF-XYR2-CYC1 This work
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densitometry of specific protein in SDS–PAGE. For Y. 
lipolytica lysates, protein normalization was to total cel-
lular protein determined by a Bradford assay.
Quantitative reverse transcription PCR
Yarrowia lipolytica transformants grown under different 
carbon conditions were subject to RNA extraction dur-
ing early exponential phase and late exponential phase. 
Prior to RNA extractions, all cultures were normalized to 
an OD600 of 10. For total RNA extraction, the cells were 
spun down at 6000×g for 2 min and normalized to and 
OD600 of 10. RNA was extracted using the E.Z. N.A. Yeast 
RNA kit. RNA extracts were stored at −80 °C.
Prior to performing any quantitative PCR (qPCR) 
experiments, qPCR primers for β-actin, TEF, XYR1, 
XYR2, XDH, and XKS (Additional file  4, Oligos 57–64) 
were tested for efficiency; only primer pairs with priming 
efficiencies between 90–110 % were used for subsequent 
qPCR experiments. A two-step protocol was employed 
for these experiments. 500 ng of total RNA was used to 
make cDNA with the Oligo-dT priming cDNA synthe-
sis kit from Thermo Scientific (Waltham, MA). A vol-
ume of 1.5  μL of the cDNA synthesis mix was used for 
each qPCR experiment using the Maxima SYBR Green/
Fluorescein qPCR master mix purchased from Thermo 
Scientific. All experiments were performed in biologi-
cal triplicates in 96 well plates using the CFX Connect 
Real-Time Thermocycler (Bio-Rad). Two reference 
genes (β-actin and TEF) were used to validate trends in 
expression.
For qPCR, copy numbers for the expression of each 
of the genes described above were calculated from their 
respective gene amplification standard curves. The copy 
number of each gene was normalized against the copy 
number of the reference gene within the same sample to 
account for any discrepancies in either RNA or cDNA 
loading during the experiments. Relative qPCR was per-
formed to observe any trends in inducibility of genes in 
xylose metabolism. The control sample employed for 
these experiments was transformants that were grown in 
glucose to contrast against the experimental samples that 
were grown in d-xylitol or d-xylose. Priming efficiencies 
were considered when analyzing normalized expression 
values for each of the xylose metabolizing genes.
Glucose and xylose assays
Glucose and xylose assays were performed in pH 7.0 
sodium phosphate buffer made from sodium phosphate 
dibasic and sodium phosphate monohydrate salts. 50-μL 
culture samples were removed from the culture every 
two days, centrifuged at 12,000×g for 4 min, and 40 μL 
of supernatant was stored at −20 °C. Samples for xylose 
assay were diluted 1:20 with YSC-LEU-URA media. 
Hexokinase treatment even though no glucose was used. 
XDH/XMR enzyme was diluted 1:4 prior to treatment. 
The Epoch 2 Microplate Spectrophotometer (BioTek) 
was used to measure endpoint reaction absorbance. The 
kinetic assay was run at 25 °C with absorbance measure-
ments taken every minute for 1  h at 340  nm with con-
tinuous orbital shaking.
Dry cell weight and lipid analysis
10 mL of cell culture was washed with ddH2O three times 
and dried overnight at 104 °C. Dry cell weight was meas-
ured using an analytical balance. To identify and quan-
tify lipids in cell biomass, lipids were transesterified to 
FAMEs as described previously [17]. Briefly, 1-mL cell 
culture was washed with ddH2O. 100 μL glyceryl trihep-
tadecanoate (2 mg μL−1 methanol) was added to the cell 
pellet and internal standard. Lipids were transesterified 
to FAMEs with 500 μL of 0.5 N sodium methoxide (20 g 
L−1 sodium hydroxide in methanol) followed by 40 min 
of vortexing at 2000  rpm. The solution was then neu-
tralized with 40 μL sulfuric acid. FAMEs were extracted 
by adding 850  μL hexane followed by 20  min vortexing 
at 2000  rpm. The mixture was centrifuged for 1  min at 
8000  rpm and the hexane layer (750  μL) was collected 
for GC–FID analysis (Agilent 7890B). Samples were 
injected with an injection volume of 1  μL, split ratio of 
10, and injector temperature of 250  °C. FAME species 
were separated on an Agilent J&W DB-23 capillary col-
umn (30 m × 0.25 mm × 0.15 μm), with helium carrier 
gas at a flow rate of 1  mL  min−1. The temperature of 
the oven started from 175  °C, held for 1  min, and then 
ramped to 200 °C within 5 min. The FID was operated at 
a temperature of 280 °C with a helium make up gas flow 
of 25 mL min−1, hydrogen flow of 30 mL min−1, and air 
flow of 300 mL min−1.
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Additional file 1. Overexpression of XDH and XKS do not confer a 
growth advantage in glucose media. Growth curves of XDH-XKS strain 
and empty vector in 2 % glucose.
Additional file 2. Candidate XYR genes in Y. lipolytica by BLAST analysis. 
A list of the putative XYR genes that were screened in this study, with their 
NCBI accession numbers and their % identity to S. stipitis XYR.
Additional file 3. SDS-PAGE of XDH, XYR1, and XYR2 in E. coli BL21 
lysates. SDS-PAGE data showing the abundance of insoluble and soluble 
protein from E. coli overexpression of the following enzymes: XDH, XYR1 
or XYR2.
Additional file 4. Oligonucleotides used in this study. A complete list of 
all of the oligonucleotides we used throughout this manuscript.
Additional file 5. SLIC cloning table. A complete list of all plasmids and 
the construction strategy we used throughout this manuscript.
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